Piero Pollesello

Orion Pharma, Espoo, Finland

  • OrcidID

Articles by Piero Pollesello

Levosimendan in Europe and China: An Appraisal of Evidence and Context

Xiangqing Kong, Xinqun Hu, Baotong Hua, et al

Published:

Citation: European Cardiology Review 2021;16:e42.

DOI:

https://doi.org/10.15420/ecr.2021.41
Haemodynamic Balance in Acute and Advanced Heart Failure: An Expert Perspective on the Role of Levosimendan

Piergiuseppe Agostoni, Dimitrios T Farmakis, Jose M García-Pinilla, et al

Published:

Citation: Cardiac Failure Review 2019;5(3):155–61.

DOI:

https://doi.org/10.15420/cfr.2019.01.R1
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use

Zoltán Papp, Piergiuseppe Agostoni, Julian Alvarez, et al

Published:

Citation: Cardiac Failure Review 2020;6:e19.

DOI:

https://doi.org/10.15420/cfr.2020.03